{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:09Z","timestamp":1787020629730,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Q-support Foundation","award":["UMCN-140928-00"],"award-info":[{"award-number":["UMCN-140928-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1906-3","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:04:43Z","timestamp":1557831883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-6022","authenticated-orcid":false,"given":"Ruud P. H.","family":"Raijmakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F. M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan P.","family":"Keijmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Roerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal P.","family":"Bleeker-Rovers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"1","key":"1906_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/CMR.00045-16","volume":"30","author":"C Eldin","year":"2017","unstructured":"Eldin C, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017;30(1):115\u201390.","journal-title":"Clin Microbiol Rev"},{"issue":"9511","key":"1906_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(06)68266-4","volume":"367","author":"NR Parker","year":"2006","unstructured":"Parker NR, Barralet JH, Bell AM. Q fever. Lancet. 2006;367(9511):679\u201388.","journal-title":"Lancet"},{"issue":"4","key":"1906_CR3","doi-asserted-by":"publisher","first-page":"e00175-11","DOI":"10.1128\/mBio.00175-11","volume":"2","author":"PA Beare","year":"2011","unstructured":"Beare PA, et al. Dot\/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. MBio. 2011;2(4):e00175-11.","journal-title":"MBio"},{"issue":"5","key":"1906_CR4","doi-asserted-by":"publisher","first-page":"e1002056","DOI":"10.1371\/journal.ppat.1002056","volume":"7","author":"KL Carey","year":"2011","unstructured":"Carey KL, et al. The Coxiella burnetii Dot\/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication. PLoS Pathog. 2011;7(5):e1002056.","journal-title":"PLoS Pathog"},{"key":"1906_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1128\/JCM.03221-13","volume":"52","author":"LM Kampschreur","year":"2014","unstructured":"Kampschreur LM, et al. Chronic Q fever in the Netherlands five years after the start of the Q fever epidemic: results from the Dutch Chronic Q Fever Database. J Clin Microbiol. 2014;52:1637\u201343.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1906_CR6","doi-asserted-by":"publisher","first-page":"e0155884","DOI":"10.1371\/journal.pone.0155884","volume":"11","author":"G Morroy","year":"2016","unstructured":"Morroy G, et al. Fatigue following acute Q-fever: a systematic literature review. PLoS ONE. 2016;11(5):e0155884.","journal-title":"PLoS ONE"},{"issue":"8","key":"1906_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/cid\/cix013","volume":"64","author":"SP Keijmel","year":"2017","unstructured":"Keijmel SP, et al. Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure Study): a randomized controlled trial. Clin Infect Dis. 2017;64(8):998\u20131005.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1906_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/qjmed\/91.8.549","volume":"91","author":"IA Penttila","year":"1998","unstructured":"Penttila IA, et al. Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM. 1998;91(8):549\u201360.","journal-title":"QJM"},{"issue":"4","key":"1906_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jinf.2016.01.004","volume":"72","author":"SP Keijmel","year":"2016","unstructured":"Keijmel SP, et al. Altered interferon-gamma response in patients with Q-fever fatigue syndrome. J Infect. 2016;72(4):478\u201385.","journal-title":"J Infect"},{"issue":"7","key":"1906_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10096-018-3265-z","volume":"37","author":"RPH Raijmakers","year":"2018","unstructured":"Raijmakers RPH, et al. Interferon-gamma and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome. Eur J Clin Microbiol Infect Dis. 2018;37(7):1385\u201391.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"1906_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jinf.2019.01.006","volume":"78","author":"RPH Raijmakers","year":"2019","unstructured":"Raijmakers RPH, et al. Cytokine profiles in patients with Q fever fatigue syndrome. J Infect. 2019;78(5):349\u201357.","journal-title":"J Infect."},{"issue":"4","key":"1906_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpsychores.2015.07.005","volume":"79","author":"SP Keijmel","year":"2015","unstructured":"Keijmel SP, et al. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. J Psychosom Res. 2015;79(4):295\u2013302.","journal-title":"J Psychosom Res"},{"key":"1906_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbi.2015.07.004","volume":"50","author":"S Blundell","year":"2015","unstructured":"Blundell S, et al. Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav Immun. 2015;50:186\u201395.","journal-title":"Brain Behav Immun"},{"issue":"34","key":"1906_CR14","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","volume":"114","author":"JG Montoya","year":"2017","unstructured":"Montoya JG, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114(34):E7150\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1906_CR15","doi-asserted-by":"publisher","first-page":"e0186802","DOI":"10.1371\/journal.pone.0186802","volume":"12","author":"C Tomas","year":"2017","unstructured":"Tomas C, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. 2017;12(10):e0186802.","journal-title":"PLoS ONE"},{"key":"1906_CR16","doi-asserted-by":"publisher","first-page":"e6500","DOI":"10.7717\/peerj.6500","volume":"7","author":"C Tomas","year":"2019","unstructured":"Tomas C, et al. Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types. PeerJ. 2019;7:e6500.","journal-title":"PeerJ"},{"issue":"1","key":"1906_CR17","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1038\/s41598-019-39060-1","volume":"9","author":"M Venter","year":"2019","unstructured":"Venter M, et al. MtDNA population variation in myalgic encephalomyelitis\/chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci Rep. 2019;9(1):2914.","journal-title":"Sci Rep"},{"key":"1906_CR18","unstructured":"Timen A, et al. Multidisciplinaire LCI-richtlijn Q-koorts-vermoeidheidssyndroom (QVS). In: Milieu RvVe, editor. Rijksinstituut voor Volksgezondheid en Milieu; 2011. p. 57."},{"issue":"5","key":"1906_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","volume":"38","author":"JH Vercoulen","year":"1994","unstructured":"Vercoulen JH, et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383\u201392.","journal-title":"J Psychosom Res"},{"issue":"8","key":"1906_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/0277-9536(92)90240-Q","volume":"35","author":"AF de Bruin","year":"1992","unstructured":"de Bruin AF, et al. Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992;35(8):1003\u201314.","journal-title":"Soc Sci Med"},{"issue":"11","key":"1906_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2015.1346","volume":"313","author":"EW Clayton","year":"2015","unstructured":"Clayton EW. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101\u20132.","journal-title":"JAMA"},{"issue":"1\u20132","key":"1906_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0022-1759(03)00231-X","volume":"278","author":"U Repnik","year":"2003","unstructured":"Repnik U, Knezevic M, Jeras M. Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods. 2003;278(1\u20132):283\u201392.","journal-title":"J Immunol Methods"},{"issue":"1","key":"1906_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1906_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/bioinformatics\/btq057","volume":"26","author":"TD Wu","year":"2010","unstructured":"Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics. 2010;26(7):873\u201381.","journal-title":"Bioinformatics"},{"issue":"3","key":"1906_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbi.2010.12.001","volume":"25","author":"TC Neylan","year":"2011","unstructured":"Neylan TC, et al. Suppressed monocyte gene expression profile in men versus women with PTSD. Brain Behav Immun. 2011;25(3):524\u201331.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1906_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tem.2013.01.005","volume":"24","author":"C Lee","year":"2013","unstructured":"Lee C, Yen K, Cohen P. Humanin: a harbinger of mitochondrial-derived peptides? Trends Endocrinol Metab. 2013;24(5):222\u20138.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1906_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2015.02.009","volume":"21","author":"C Lee","year":"2015","unstructured":"Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443\u201354.","journal-title":"Cell Metab"},{"issue":"10","key":"1906_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12(10):685\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"1906_CR29","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1113\/JP274472","volume":"595","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, et al. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613\u201321.","journal-title":"J Physiol"},{"issue":"12","key":"1906_CR30","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1091\/mbc.e09-02-0168","volume":"20","author":"Y Hashimoto","year":"2009","unstructured":"Hashimoto Y, et al. Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha\/WSX-1\/gp130. Mol Biol Cell. 2009;20(12):2864\u201373.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"1906_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11064-012-0951-6","volume":"38","author":"ST Zhao","year":"2013","unstructured":"Zhao ST, Zhao L, Li JH. Neuroprotective peptide humanin inhibits inflammatory response in astrocytes induced by lipopolysaccharide. Neurochem Res. 2013;38(3):581\u20138.","journal-title":"Neurochem Res"},{"key":"1906_CR32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/pedi.12685","volume":"19","author":"C Du","year":"2018","unstructured":"Du C, et al. Circulating MOTS-c levels are decreased in obese male children and adolescents and associated with insulin resistance. Pediatr Diabetes. 2018;19:1058\u201364.","journal-title":"Pediatr Diabetes"},{"key":"1906_CR33","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/jim-2017-000681","volume":"66","author":"LR Cataldo","year":"2018","unstructured":"Cataldo LR, et al. Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals. J Investig Med. 2018;66:1019\u201322.","journal-title":"J Investig Med"},{"issue":"1","key":"1906_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12967-017-1371-9","volume":"15","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, et al. Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment. J Transl Med. 2017;15(1):267.","journal-title":"J Transl Med"},{"issue":"3","key":"1906_CR35","first-page":"208","volume":"5","author":"NE Booth","year":"2012","unstructured":"Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Int J Clin Exp Med. 2012;5(3):208\u201320.","journal-title":"Int J Clin Exp Med"},{"issue":"37","key":"1906_CR36","doi-asserted-by":"publisher","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","volume":"113","author":"RK Naviaux","year":"2016","unstructured":"Naviaux RK, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113(37):E5472\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1906_CR37","doi-asserted-by":"publisher","first-page":"E910","DOI":"10.1073\/pnas.1618447114","volume":"114","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, Bronkhorst EM, van der Meer JW. Metabolome of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2017;114(6):E910.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1906_CR38","first-page":"1","volume":"2","author":"S Myhill","year":"2009","unstructured":"Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2(1):1\u201316.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"1906_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-017-0628-x","volume":"19","author":"M Gerwyn","year":"2017","unstructured":"Gerwyn M, Maes M. Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): a review of recent findings. Curr Rheumatol Rep. 2017;19(1):1.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1906_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12920-017-0248-3","volume":"10","author":"WC de Vega","year":"2017","unstructured":"de Vega WC, et al. Epigenetic modifications and glucocorticoid sensitivity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). BMC Med Genomics. 2017;10(1):11.","journal-title":"BMC Med Genomics"},{"issue":"3","key":"1906_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/039463200902200326","volume":"22","author":"T Pietrangelo","year":"2009","unstructured":"Pietrangelo T, et al. Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome. Int J Immunopathol Pharmacol. 2009;22(3):795\u2013807.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"1906_CR42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.113.131045","volume":"55","author":"Y Nakatomi","year":"2014","unstructured":"Nakatomi Y, et al. Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an (1)(1)C-(R)-PK11195 PET study. J Nucl Med. 2014;55(6):945\u201350.","journal-title":"J Nucl Med"},{"issue":"4","key":"1906_CR43","doi-asserted-by":"publisher","first-page":"796","DOI":"10.18632\/aging.100943","volume":"8","author":"LJ Cobb","year":"2016","unstructured":"Cobb LJ, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging. 2016;8(4):796\u2013809.","journal-title":"Aging"},{"issue":"1\u20132","key":"1906_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis I, et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell. 2018;172(1\u20132):147\u2013161-e12.","journal-title":"Cell"},{"issue":"7","key":"1906_CR45","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/j.1460-2075.1991.tb07715.x","volume":"10","author":"TC Cox","year":"1991","unstructured":"Cox TC, et al. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 1991;10(7):1891\u2013902.","journal-title":"EMBO J"},{"issue":"2","key":"1906_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00062752-199603020-00011","volume":"3","author":"EJ Fitzsimons","year":"1996","unstructured":"Fitzsimons EJ, May A. The molecular basis of the sideroblastic anemias. Curr Opin Hematol. 1996;3(2):167\u201372.","journal-title":"Curr Opin Hematol"},{"key":"1906_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.01.020","author":"M Balwani","year":"2019","unstructured":"Balwani M. Erythropoietic protoporphyria and X-linked protoporphyria: pathophysiology, genetics, clinical manifestations, and management. Mol Genet Metab. 2019;. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2019.01.020\n                    \n                  .","journal-title":"Mol Genet Metab."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1906-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T19:21:45Z","timestamp":1589311305000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1906-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1906-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent and the study was approved by the Medical Ethical Review Committee of the Arnhem-Nijmegen region.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}